While industry groups decried the Trump administration’s new drug pricing order, analysts say it lacked details and the teeth ...

As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

The package revives President Donald Trump’s much-maligned Most Favored Nations rule but goes further into the private ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

Roche committed $50 billion in U.S. manufacturing funds, with which it will construct at least four new facilities.

The FDA and CDC have also recommended pausing the use of Ixchiq in seniors 60 years and older while safety investigations are ...

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...

At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a ...

While Quantum computing has been reported to be five years away for many years now, companies are preparing for it by setting ...

To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of ...

With President Donald Trump expected to deliver a drug pricing order on Monday that Big Pharma and patient groups alike have ...

The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the ...